Bayer | BAYN - PE Price to Earnings


Bayer reported 3.4 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Air Liquide 25.71 0.96 Dec/2025
Akzo Nobel 43.06 137.5 Mar/2026
Alcon AG 36.42 1.77 Mar/2026
Amarin 91.05 88.3 Jun/2023
Arkema 37.77 11.36 Mar/2026
AstraZeneca 29.59 2.3 Mar/2026
BASF 16.65 11.07 Mar/2026
Bayer 3.4 8.75 Mar/2026
Beiersdorf 22.05 2.86 Dec/2025
Corteva 26.61 0.53 Mar/2026
Covestro 7.54 0 Jun/2024
Essilor 54.18 94.64 Dec/2025
Fresenius 15.18 0.63 Dec/2025
Fresenius Medical Care 6.64 2.07 Mar/2026
Genmab 17.14 4.39 Dec/2025
Givaudan 27.41 4.3 Dec/2025
GlaxoSmithKline 14.87 3.72 Mar/2026
GRIFOLS 10.98 5.83 Mar/2026
Henkel 12.8 0.76 Dec/2025
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Johnson Matthey 36.25 18.8 Jun/2026
Linde 24.82 3.72 Dec/2025
Lonza 34.34 2.58 Dec/2025
Merck 12.74 7.82 Mar/2026
Novartis 20.17 2.32 Mar/2026
Nutrien 14.33 2.05 Mar/2026
Philips 14.32 1.33 Mar/2026
PPG Industries 14.05 4.96 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.84 0.14 Mar/2026
SAP 30.9 2.1 Dec/2025
Solvay 9.7 0.87 Mar/2026
UCB 29.7 5.52 Dec/2025
Umicore 4.86 1.8 Dec/2025
Vinci 14 1.54 Dec/2025